West Pharmaceutical Servs (NYSE:WST) reported its Q4 earnings results on Thursday, February 17, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
Earnings
West Pharmaceutical Servs beat estimated earnings by 6.81%, reporting an EPS of $2.04 versus an estimate of $1.91.
Revenue was up $150.60 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.26, which was followed by a 2.08% increase in the share price the next day.
Here's a look at West Pharmaceutical Servs's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 1.80 | 1.74 | 1.43 | 1.12 |
| EPS Actual | 2.06 | 2.46 | 2.05 | 1.34 |
| Revenue Estimate | 687.09M | 669.38M | 611.39M | 543.67M |
| Revenue Actual | 706.50M | 723.60M | 670.70M | 580.20M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
